Navigation Links
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Date:8/21/2008

ar. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals, Inc.

(1) Ferlay J, et al., GLOBOCAN 2002. Cancer Incidence, Mortality and

Prevalence Worldwide. IARC CancerBase No.5, Version 2.0. IARCPress,

Lyon, 2004. Available at: http://www-dep.iarc.fr. Accessed May 2008.

(2) 2005 Cancer Register System (CRS) annual report,

http://crs.cph.ntu.edu.tw/crs_c/annual.html. Accessed May 12, 2008.

(3) Del Pozo AC, Lopez P. Management of hepatocellular carcinoma. Clin

Liver Dis 2007 May;11(2):305-21.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCarePharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
2. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
6. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
7. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
8. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Mass. , Sept. 18, 2014 /PRNewswire/ ... ), a biotechnology company focused on discovering, ... unmet medical needs using RNA-targeted technologies, today announced ... Officer, Dr. Geert Cauwenbergh , will ... BioPharm America™ Conference on Wednesday, September 24, ...
(Date:9/17/2014)... , Sept. 17, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com ... Methacrylate (MMA) Industry" and "2014 Market Research Report ... reports to its store. Photo - ... Research Report on Global Methyl Methacrylate (MMA) Industry" ... China and Global Methyl ...
(Date:9/17/2014)... YORK , Sept. 17, 2014 ... Summary GlobalData,s new report, "Germany Gynecological ... data on the Germany Gynecological Devices market. The ... volume (in units) and average prices (in US ... (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices ...
Breaking Medicine Technology:RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3
... ANGELES, Sept. 29, 2011 A west coast secret is ... All the way from Beverly Hills, California, a health and ... headlines ( www.endlessyouthandlife.com ).  A clinically tested dietary supplement is ... shown in less than 4 weeks of use.  Just a ...
... Awarepoint Corporation , the leading provider ... announced today that it received Frost & Sullivan,s ... Strategy Leadership Award .  The award recognizes ... and workflow automation solutions that significantly differentiates Awarepoint ...
Cached Medicine Technology:Beverly Hills Secret Now Helping People Across The Country 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 3
(Date:9/18/2014)... Springs, FL (PRWEB) September 18, 2014 It ... and run, sprint or walk for healthier and happier kids. ... support and participate in the 4th Annual Miami Children’s Hospital ... Wheels. http://www.hyundaihopeonwheels.org , The 5K will ... finishing location will be outside of Coral Gables City Hall ...
(Date:9/18/2014)... 2014 CRDF Global released today ... digital edition – rich with videos, images and ... CRDF Global empowers scientists and innovators around the ... corporate, foundation and individual supporters, CRDF Global reaches ... research, training and entrepreneurship. , The Annual Report ...
(Date:9/18/2014)... Clinical trial report, “Edema Global Clinical Trials Review, ... scenario. This report provides elemental information and data relating ... overview of the trial numbers and their recruitment status ... globe. The databook offers a preliminary coverage of disease ... the sponsors and also provides briefing pertaining to the ...
(Date:9/18/2014)... September 18, 2014 Research conducted by ... Allegheny Health Network has documented improved survival in ... removal of the tumors along with stereotactic radiosurgery. , ... ASTRO (American Society for Radiation Oncology) this ... numerous precisely focused radiation beams to treat tumors in ...
(Date:9/18/2014)... 18, 2014 Good Neighbor Pharmacy, ... of Good Neighbor Pharmacy University, an online central ... will educate and empower pharmacy owners and their ... industry continues to evolve, Good Neighbor Pharmacy is ... resources and tools to help their businesses thrive,” ...
Breaking Medicine News(10 mins):Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 3Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 3Health News:Good Neighbor Pharmacy University Keeps Pharmacists Ahead of the Curve 2
... attention-deficit/hyperactivity disorder, is among the costliest of behavioral ... leads to accidental injuries, school failure, substance abuse, ... century of study, the disorder,s roots remain mysterious. ... on heritability of the condition, and indeed evidence ...
... Brigham and Women,s Hospital in Boston suggests that improvements in ... cases of ear infections in children. Ear ... with annual direct and indirect costs of $3 billion to ... "We believe these findings, which demonstrate a direct correlation between ...
... for suspected developmental delays , THURSDAY, Jan. 28 (HealthDay ... of screening children for developmental delays, many fail to refer ... "The ultimate goal of screening is to improve outcomes for ... that many pediatricians did not act properly even when serious ...
... , , URAC,s 2010 ... Programs , WASHINGTON , Jan. 28 ... organization, has issued a call for entries for its 2010 Best ... which companies are setting the standard in advancing the role of consumers ...
... , Emergency Relief Fund Established for Haitian Senior Living ... The Assisted Living Federation of America (ALFA) has ... of senior living companies. , "The employees of our members devote ... in their hour of need, we offer support to them so ...
... have discovered a new strategy for making embryonic stem cell ... system. This strategy, described in a new research report appearing ... Journal ( http://www.fasebj.org ), involves fusing bone marrow cells ... DNA from both the donor and recipient, raising hopes that ...
Cached Medicine News:Health News:Study says lead may be the culprit in ADHD 2Health News:Improved air quality linked to fewer pediatric ear infections 2Health News:Kids' Screenings in Place, But Referrals Lacking 2Health News:Which Health Care Organizations Are Advancing Consumer Protection and Empowerment? 2Health News:Which Health Care Organizations Are Advancing Consumer Protection and Empowerment? 3Health News:Which Health Care Organizations Are Advancing Consumer Protection and Empowerment? 4Health News:ALFA Extends Helping Hand to Haiti 2Health News:Stem cell breakthrough: Bone marrow cells are the answer 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: